0409-6648-02 · Dextrose Monohydrate 50% Injection · Hospira, Inc., a Pfizer Company
What is the status for 0409-6648-02 · Dextrose Monohydrate 50% Injection · Hospira, Inc., a Pfizer Company?
For 0409-6648-02, generic name is Dextrose Monohydrate 50% Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Limited Availability; initial posting date is 01/13/2022, recorded from its source on 2026-11-03.
"initial_posting_date": "01/13/2022", "package_ndc": "0409-6648-02", "generic_name": "Dextrose Monohydrate 50% Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay"
— api.fda.gov, retrieved 2026-11-03
- Package NDC
- 0409-6648-02 verified
- Generic name
- Dextrose Monohydrate 50% Injection verified
- Manufacturer
- Hospira, Inc., a Pfizer Company verified
- Status
- Current verified
- Availability now
- Limited Availability verified
- FDA note
- Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay verified
- Initial posting date
- 01/13/2022 verified
- Last update date
- 10/27/2026 verified
- Days in shortage
- 1756 our reading
- Reason for shortage
- Other verified
- Dosage form
- Injection verified
- Therapeutic category
- Endocrinology/Metabolism verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "10/27/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02)", "company_name": "Hospira, Inc., a Pfizer Company", "shortage_reason": "Other", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-03
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2050%25%20Injection%22+AND+status%3A%22Current%22&limit=1000